BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28286044)

  • 21. Prognostic implications of lymph node metastases in carcinoma of the body and tail of the pancreas.
    Sahin TT; Fujii T; Kanda M; Nagai S; Kodera Y; Kanzaki A; Yamamura K; Sugimoto H; Kasuya H; Nomoto S; Takeda S; Morita S; Nakao A
    Pancreas; 2011 Oct; 40(7):1029-33. PubMed ID: 21705947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems.
    Benetatos N; Hodson J; Marudanayagam R; Sutcliffe RP; Isaac JR; Ayuk J; Shah T; Roberts KJ
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):169-175. PubMed ID: 29576279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection.
    Ozaki H; Hiraoka T; Mizumoto R; Matsuno S; Matsumoto Y; Nakayama T; Tsunoda T; Suzuki T; Monden M; Saitoh Y; Yamauchi H; Ogata Y
    Surg Today; 1999; 29(1):16-22. PubMed ID: 9934826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective.
    Picozzi VJ; Oh SY; Edwards A; Mandelson MT; Dorer R; Rocha FG; Alseidi A; Biehl T; Traverso LW; Helton WS; Kozarek RA
    Ann Surg Oncol; 2017 Jun; 24(6):1722-1730. PubMed ID: 28054192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.
    Johnston WC; Hoen HM; Cassera MA; Newell PH; Hammill CW; Hansen PD; Wolf RF
    HPB (Oxford); 2016 Jan; 18(1):21-8. PubMed ID: 26776847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection.
    Shirai Y; Shiba H; Haruki K; Horiuchi T; Saito N; Fujiwara Y; Sakamoto T; Uwagawa T; Yanaga K
    Anticancer Res; 2017 Feb; 37(2):787-793. PubMed ID: 28179331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.
    Kim Y; Kim SC; Song KB; Kim J; Kang DR; Lee JH; Park KM; Lee YJ
    HPB (Oxford); 2016 Apr; 18(4):325-31. PubMed ID: 27037201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Berger AC; Watson JC; Ross EA; Hoffman JP
    Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters.
    Crippa S; Partelli S; Bassi C; Berardi R; Capelli P; Scarpa A; Zamboni G; Falconi M
    Surgery; 2016 Mar; 159(3):862-71. PubMed ID: 26602841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of facility type on survival outcomes after pancreatectomy for pancreatic adenocarcinoma.
    Chu QD; Zhou M; Peddi P; Medeiros KL; Zibari GB; Shokouh-Amiri H; Wu XC
    HPB (Oxford); 2017 Dec; 19(12):1046-1057. PubMed ID: 28967535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association.
    Turrini O; Paye F; Bachellier P; Sauvanet A; Sa Cunha A; Le Treut YP; Adham M; Mabrut JY; Chiche L; Delpero JR;
    Eur J Surg Oncol; 2013 Feb; 39(2):171-8. PubMed ID: 22999411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy.
    Tzeng CW; Fleming JB; Lee JE; Wang X; Pisters PW; Vauthey JN; Varadhachary G; Wolff RA; Katz MH
    HPB (Oxford); 2012 Jun; 14(6):365-72. PubMed ID: 22568412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre.
    Barugola G; Partelli S; Crippa S; Butturini G; Salvia R; Sartori N; Bassi C; Falconi M; Pederzoli P
    HPB (Oxford); 2013 Dec; 15(12):958-64. PubMed ID: 23490217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy.
    Christians KK; Heimler JW; George B; Ritch PS; Erickson BA; Johnston F; Tolat PP; Foley WD; Evans DB; Tsai S
    Surgery; 2016 Mar; 159(3):893-900. PubMed ID: 26602840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Span-1 and CA19-9 as Predictors of Early Recurrence and Lymph Node Metastasis for Patients with Invasive Pancreatic Cancer after Pancreatectomy.
    Shimizu T; Asakuma M; Tomioka A; Inoue Y; Hirokawa F; Hayashi M; Uchiyama K
    Am Surg; 2018 Jan; 84(1):109-113. PubMed ID: 29428036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
    Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
    Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of fecal elastase-1 and pancreatic function testing in children.
    Wali PD; Loveridge-Lenza B; He Z; Horvath K
    J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):277-80. PubMed ID: 22266489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortalin expression in pancreatic cancer and its clinical and prognostic significance.
    Cui X; Li Z; Piao J; Li J; Li L; Lin Z; Jin A
    Hum Pathol; 2017 Jun; 64():171-178. PubMed ID: 28412209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.